IL33 and lung cancer: In the first case, Wang and collaborators showed that the IL-33/ST2 pathway up-regulated membrane glucose transporter 1 in non-small-cell lung cancer cells, enhancing their glucose uptake and glycolysis, thus favoring in vitro outgrowth of human lung cancer and its metastasis in a mouse model (60).